| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Acute bacterial maxillary sinusitis: Results of U.S. and European comparative therapy trials
|
Nielsen, Richard W.
|
|
1992
|
92 |
6S1 |
p. S70-S73
4 p.
|
article
|
| 2 |
Acute bronchitis: Results of U.S. and European trials of antibiotic therapy
|
Dere, Willard H.
|
|
1992
|
92 |
6S1 |
p. S53-S57
5 p.
|
article
|
| 3 |
Advances in outpatient antimicrobial therapy: Loracarbef
|
Moellering Jr., Robert C.
|
|
1992
|
92 |
6S1 |
p. S1-
1 p.
|
article
|
| 4 |
Adverse effects of neutrophils on the lung
|
Gadek, James E.
|
|
1992
|
92 |
6S1 |
p. S27-S31
5 p.
|
article
|
| 5 |
Antibiotic therapy for urinary tract infections
|
Iravani, Abdollah
|
|
1992
|
92 |
6S1 |
p. S95-S100
6 p.
|
article
|
| 6 |
Efficacy and safety of loracarbef in the treatment of pneumonia
|
Hyslop, David L.
|
|
1992
|
92 |
6S1 |
p. S65-S69
5 p.
|
article
|
| 7 |
Gene therapy strategies for pulmonary disease
|
Crystal, Ronald G.
|
|
1992
|
92 |
6S1 |
p. S44-S52
9 p.
|
article
|
| 8 |
Inflammation and airway reactivity in asthma
|
Pueringer, Robert J.
|
|
1992
|
92 |
6S1 |
p. S32-S38
7 p.
|
article
|
| 9 |
In vitro activity of loracarbef and effects of susceptibility test methods
|
Doern, Gary
|
|
1992
|
92 |
6S1 |
p. S7-S15
9 p.
|
article
|
| 10 |
Loracarbef (LY163892) in the treatment of acute exacerbations of chronic bronchitis: Results of U.S. and European comparative clinical trials
|
Zeckel, Michael L.
|
|
1992
|
92 |
6S1 |
p. S58-S64
7 p.
|
article
|
| 11 |
Loracarbef (LY163892) versus cefaclor and norfloxacin in the treatment of uncomplicated pyelonephritis
|
Hyslop, David L.
|
|
1992
|
92 |
6S1 |
p. S86-S94
9 p.
|
article
|
| 12 |
Loracarbef (LY163892) versus cefaclor in the treatment of bacterial skin and skin-structure infections in an adult population
|
McCarty, James
|
|
1992
|
92 |
6S1 |
p. S80-S85
6 p.
|
article
|
| 13 |
Loracarbef versus penicillin VK in the treatment of streptococcal pharyngitis and tonsillitis in an adult population
|
McCarty, James
|
|
1992
|
92 |
6S1 |
p. S74-S79
6 p.
|
article
|
| 14 |
Pathogenesis of fibrosis in acute lung injury
|
Bitterman, Peter B.
|
|
1992
|
92 |
6S1 |
p. S39-S43
5 p.
|
article
|
| 15 |
Pharmacokinetic profile of loracarbef
|
DeSante, Karl A.
|
|
1992
|
92 |
6S1 |
p. S16-S19
4 p.
|
article
|
| 16 |
Preclinical data and clinical experience with loracarbef: A summary
|
Moellering Jr, Robert C.
|
|
1992
|
92 |
6S1 |
p. S101-S103
3 p.
|
article
|
| 17 |
Publisher's note
|
|
|
1992
|
92 |
6S1 |
p. ii-
1 p.
|
article
|
| 18 |
The carbacephems: A new beta-lactam antibiotic class
|
Cooper, Robin D.G.
|
|
1992
|
92 |
6S1 |
p. S2-S6
5 p.
|
article
|
| 19 |
The safety profile of loracarbef: clinical trials in respiratory, skin, and urinary tract infections
|
Therasse, Donald G.
|
|
1992
|
92 |
6S1 |
p. S20-S25
6 p.
|
article
|
Journal description